Abstract

We previously identified a region on chromosome 1 that harbor quantitative trait loci (QTLs) with large effects on alcohol withdrawal risk using both chronic and acute models in mice. Here, using newly created and existing QTL interval-specific congenic (ISC) models, we report the first evidence that this region harbors two distinct alcohol withdrawal QTLs (Alcw11and Alcw12), which underlie 13% and 3–6%, respectively, of the genetic variance in alcohol withdrawal severity measured using the handling-induced convulsion. Our results also precisely localize Alcw11 and Alcw12 to discreet chromosome regions (syntenic with human 1q23.1–23.3) that encompass a limited number of genes with validated genotype-dependent transcript expression and/or non-synonymous sequence variation that may underlie QTL phenotypic effects. ISC analyses also implicate Alcw11and Alcw12 in withdrawal-induced anxiety-like behavior, representing the first evidence for their broader roles in alcohol withdrawal beyond convulsions; but detect no evidence for Alcw12 involvement in ethanol conditioned place preference (CPP) or consumption. Our data point to high-quality candidates for Alcw12, including genes involved in mitochondrial respiration, spatial buffering, and neural plasticity, and to Kcnj9 as a high-quality candidate for Alcw11. Our studies are the first to show, using two null mutant models on different genetic backgrounds, that Kcnj9 −/− mice demonstrate significantly less severe alcohol withdrawal than wildtype littermates using acute and repeated exposure paradigms. We also demonstrate that Kcnj9 −/− voluntarily consume significantly more alcohol (20%, two-bottle choice) than wildtype littermates. Taken together with evidence implicating Kcnj9 in ethanol CPP, our results support a broad role for this locus in ethanol reward and withdrawal phenotypes. In summary, our results demonstrate two distinct chromosome 1 QTLs that significantly affect risk for ethanol withdrawal, and point to their distinct unique roles in alcohol reward phenotypes.

Highlights

  • Abuse of alcohol, prescription and other sedative-hypnotic drugs is among the top five health problems identified in the U.S (Office of National Drug Control Policy, 2004)

  • Using newly created and existing quantitative trait locus (QTL) interval-specific congenic (ISC) models, we report the first evidence that this region harbors two distinct alcohol withdrawal QTLs (Alcw11and Alcw12), which underlie 13% and 3–6%, respectively, of the genetic variance in alcohol withdrawal severity measured using the handlinginduced convulsion

  • The present studies report the creation of an ISC model (R3), analyses of which proved invaluable to confirm that at least two distinct alcohol withdrawal QTLs on chromosome 1 exist within the original broad Alcw1 region (Buck et al, 1997), and we demonstrate that each significantly affects alcohol withdrawal risk

Read more

Summary

Introduction

Prescription and other sedative-hypnotic drugs is among the top five health problems identified in the U.S (Office of National Drug Control Policy, 2004). Alcoholism is a heterogeneous disorder with a complex interaction between genetic and environmental factors, making conclusive identification of genetic determinants difficult to elucidate (Ducci and Goldman, 2012). This continues to hamper development of effective therapeutic and prevention strategies. We previously mapped significant quantitative trait loci (QTLs) with large effects on predisposition to physiological dependence and associated withdrawal convulsions following chronic and acute alcohol exposure in mice (Buck et al, 1997, 2002) to a broad region of chromosome 1

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call